Gene · 708
NIH grants1,264
NIH grants whose papers are about the gene, through NIH's grant-paper links.
601 to 620 of 1,264
Download this page as JSON| Grant | Title | C1QBP papers | Newest fiscal year |
|---|---|---|---|
| R01AI104706 | Mechanisms of NIrp3 inflammasome activation by mitochondrial dysfunction | 1 | 2018 |
| R01AI105887 | Metabolic checkpoint in TH17 cell differentiation | 1 | 2018 |
| R01AI110201 | IL-27 and Treg cells | 1 | 2018 |
| R01AI113211 | Control of Endoplasmic Reticulum Tubule Formation by Legionella pneumophila | 1 | 2018 |
| R01CA020525 | Regulation of cell growth and proliferation by Myc | 1 | 2018 |
| R01CA135362 | Mechanisms of HTLV-I Tax-mediated NF-kB activation | 1 | 2018 |
| R01CA174836 | Oncogenic Function of ATDC in Bladder Cancer | 1 | 2018 |
| R01CA187209 | Functional analysis of BRCA1 in DNA damage response and tumor suppression | 1 | 2018 |
| R01GM065997 | Regulation of cullin - RING ubiquitin ligases | 1 | 2018 |
| R01GM090033 | Image-derived Spatiotemporal Models of Cellular Organization and Perturbation | 1 | 2018 |
| R01GM096403 | Selective Peptide-Based Oxidation Catalysts for Bioactive Molecule Synthesis | 1 | 2018 |
| R01GM108647 | Functional analysis of the TET2/OGT complex in epigenetic modifications | 1 | 2018 |
| R01GM115591 | Systematic functional annotation of the mitochondrial proteome | 1 | 2018 |
| R01GM116184 | FXI and Sepsis | 1 | 2018 |
| R01GM127212 | A Novel and High Throughput System for Drug Discovery and Testing on Multidrug Resistant HIV-1 Proteases | 1 | 2018 |
| R01HL112937 | Role of complement regulator properdin in the interaction between platelets and l | 1 | 2018 |
| R01HL122068 | Targeting beta-arrestins in Pulmonary Fibrosis | 1 | 2018 |
| R21AG054206 | A Novel RNA Binding Protein Modulates Tau Pathology | 1 | 2018 |
| R21AI124009 | Inhibition of Bacterial and Host-Derived H2S Production for the Therapeutic Enhancement of Anti-Bacterial Host Defense | 1 | 2018 |
| R21AI129369 | Rapid Phenotyping of the ZIKV Genome | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/708/grants?page=31